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INTRODUCTION
Defects in the formation or function of primary cilium result in severe pathologies such as ciliopathies and retina degeneration in human and many genes have been involved in this process. Among these genes, CRB2 (Crumbs2) has been recently implicated in several human pathologies reminiscent of ciliopathies. Indeed, CRB2 mutations have been associated in the last years with a growing body of defects that have been regrouped recently in the CRB2-related syndrome of poor prognosis resembling congenital Finnish nephrosis (Jaron et al., 2016; ; Lamont et al., 2016; ; Slavotinek et al., 2015) . This CRB2related syndrome is characterized by cystic renal disease and cerebral ventriculomegaly (Slavotinek, 2016) suggesting that ciliogenesis or ciliary functions are compromised. To support this hypothesis, it has been shown that in the zebrafish, a Crb2b isoform is essential for the elongation of the inner segment of photoreceptor (PR) and of the primary cilium of kidney cells (Hazime and Malicki, 2017; ; Omori and Malicki, 2006) . Finally, Crb3a and b isoforms are involved in primary ciliogenesis in MDCK cells (Fan et al., 2007; ; Fan et al., 2004) while Crb3a is controlling the length of the hair cell kinocilia in the zebrafish otic vesicle (Omori and Malicki, 2006) suggesting that Crumbs proteins may play an important role in ciliogenesis. Besides the ciliopathy-like syndrome, a recent study has identified a CRB2 mutation in an autosomal recessive retinitis pigmentosa (RP) (Chen et al., 2019) .
In addition to CRB2, two other human CRB genes have been identified in human, CRB1 and CRB3 (Bazellieres et al., 2009) . CRB1 mutations are associated with several retinal degenerations from severe Leber Congenital Amaurosis (LCA) to milder RP12 (den Hollander et al., 1999) that can be mimicked by either loss of Crb1 or Crb2 expression in the mouse retina (Alves et al., 2013; ; van de Pavert et al., 2004) . Lack of Crb1 expression in the mouse retina likely results in defective junctions between Müller cells and PR and it has been suggested that these junction defects lead to PR degeneration (van de Pavert et al., 2004) .
There is still however the possibility that the progressive loss of PR in the retina might be a consequence of changes in signaling pathways or in apical transport since Crumbs proteins have been involved in both processes (Gurudev et al., 2014; ; Szymaniak et al., 2015) .
All together these data suggest that CRB2 proteins might play an important role in ciliogenesis and in this study, we have uncovered a new CRB2 complex that regulate primary cilium formation that might be involved in CRB2-related syndrome.
RESULTS AND DISCUSSION

1) CRB2 is necessary for primary ciliogenesis in ARPE19 cells.
To study the role of CRB2 in primary ciliogenesis, we chose ARPE19 cells, a human retina pigmented epithelial (RPE) cell line that produces primary cilia when reaching confluency, without serum depletion (Dunn et al., 1996) . We thus transiently depleted CRB2 from ARPE19 cells using siRNA transfection ( Fig.1A,  B , C and Fig.S1A , B) and we measured the percentage of cells with a cilium, labeled by acetylated tubulin (AcTub) antibodies, compared to control cells after 7 days ( Fig.1A) . Strikingly, we observed about 5 times less cilia in CRB2 knockdown (KD) cells when compared to control cells ( Fig.1B, C) clearly showing that CRB2 is required for primary ciliogenesis. Next, we tried to localize CRB2 in ARPE19 cells but all the antibodies tested gave too much non-specific background. To circumvent this difficulty we transiently expressed CRB2 tagged with the AU1 epitope and performed co-immunostainings with antibodies against AU1 and g tubulin (gTub) on cells only expressing moderate levels of AU1::CRB2 to avoid over-expression artifacts (Fig. 1D ). We detected AU1::CRB2 at the plasma membrane, in intracellular vesicles and, interestingly, in a cluster of vesicles nearby the centrosome, although not in cilia, that could be linked to its role in ciliogenesis ( Fig.  1D) .
2) CRB2 depletion blocks the formation or the anchoring of the primary vesicle.
Since ciliogenesis was impaired in CRB2 KD cells, we next investigated at which stage it was blocked by using ODF2 (Cenexin), a marker of the maturation of the mother centriole (MC) (Ishikawa et al., 2005) and Myosin-Va (MyoVa), a protein necessary for the attachment of the ciliary vesicles to the distal appendages of the MC (Wu et al., 2018) . In CRB2 KD cells, ODF2 was present at levels equivalent to the ones found in control cells ( Fig.2A, B) indicating that the MC has reached at least a stage of maturation before axoneme growth. TEM analysis indeed, showed that most centrioles had subdistal and distal appendages in both control and CRB2 KD cells (Fig.2C ). We, however, noticed that most of the centrioles observed in CRB2 KD cells lacked a primary vesicle ( Fig.2D ) and the elongation of the axoneme was absent strongly suggesting that ciliogenesis was blocked at the stage of the ciliary vesicle formation or attachment. This lack of ciliary vesicle formation or attachment was not the consequence of a defect in MyoVa accumulation in the pericentriolar region (Wu et al., 2018) as we did not find a difference either in localization or in quantity of this protein between control and CRB2 KD cells ( Fig.2A, B ). Thus, we concluded that the defect observed in the absence of CRB2 might be the formation or the attachment of ciliary vesicle through an unknown yet mechanism to ensure their transport and anchoring to distal appendages.
3) Ciliogenesis does not require the canonical PALS1/MUPP1 complex.
Crb proteins form a complex with the cytoplasmic adapters PALS1 (MPP5) and PATJ in epithelial cells from mammals and flies (Assemat et al., 2008) while Crb1 recruits Pals1 and Mupp1 in the mouse retina (van de Pavert et al., 2004) . No study, however, has yet thoroughly investigated the proteins associated with the cytoplasmic domain of CRB2. We thus used affinity-precipitation experiments with peptides mimicking the cytoplasmic domain of CRB2 to pull down potential partners in ARPE19 cells. PALS1 and MUPP1 were identified in the pull-down experiments (Fig.3A) and by mass-spectrometry of peptide-affinity pull-down (see material and methods) demonstrating that CRB2 can recruit PALS1 and MUPP1 and that these interactions relied on the presence of the C-terminal ERLI motif that binds to the PDZ domain of PALS1 (Roh et al., 2002) . To test whether PALS1 or MUPP1 could play a role in primary ciliogenesis together with CRB2, we depleted these proteins in ARPE19 cells and quantified ciliogenesis as for CRB2 KD experiments ( Fig. S2A, B ). We found no significant effect of either protein depletion indicating that the canonical Crumbs complex does not likely play a role in impaired ciliogenesis upon CRB2 depletion. In a previous study, however, it has been shown that KD of mPals1 during early mouse cortical development led to a significant defect in ciliogenesis (Kim et al., 2010) . While we found no effect of PALS1 depletion in ARPE19 cells we cannot ascertain that the amount of PALS1 remaining in depleted cells (30% in average) does not reach below a threshold necessary to block ciliogenesis ( Fig.S2A ). Alternatively, in the mouse study, KD of Pals1 induced a loss of mCrb2 staining suggesting that the ciliogenesis phenotype could be due to the loss of mCrb2 expression rather than a direct effect of mPals1 down-regulation. MUPP1 on the other hand was strongly depleted in our in vitro conditions (11% left in average) ( Fig.S2A, B ) and yet ciliogenesis was not affected further supporting that the CRB2/PALS1/MUPP1 complex might not play a crucial role during primary ciliogenesis in ARPE19 cells.
4) CRB2 binds to PAR6a and HOOK2.
CRB3a and Crumbs proteins bind directly to PAR6a or PAR6 both in human and drosophila respectively (Kempkens et al., 2006; ; Lemmers et al., 2004) . In addition, we showed recently that HOOK2 directly interacts with PAR6a to recruit it to the centrosome (Pallesi-Pocachard et al., 2016) and that HOOK2, a microtubule-binding protein present in the centriolar region (Szebenyi et al., 2007a) , is necessary for primary ciliogenesis in ARPE19 cells (Baron Gaillard et al., 2011) . Thus, we postulated that these two proteins could be involved in CRB2 KD phenotype. To this aim, we expressed PAR6a tagged with an HA epitope in ARPE19 cells and performed CRB2 affinity pull-down experiments to test for the presence of PAR6a and HOOK2 as we did for PALS1 and MUPP1 (Fig.3A ). PAR6a was specifically enriched with the CRB2 peptide containing the ERLI motif indicating that CRB2 behaves as CRB3a (Lemmers et al., 2004) . We also detected HOOK2 together with PAR6a ( Fig.  3A) and we thus concluded that CRB2 likely binds to HOOK2 via PAR6a. To ascertain that CRB2, PAR6a and HOOK2 form a complex in ARPE19 cells we took advantage of the fact that when mHook2 was overexpressed in ARPE19 cells, its forms membranous aggregates called aggresomes (Szebenyi et al., 2007b) . When mHook2 was transiently expressed in ARPE19 cells, CRB2 and PAR6a were both recruited to mHook2 aggresomes ( Fig.S3A ) confirming that they can form a complex in cells. We also detected dynein which interacts with HOOK2 (Olenick et al., 2016) to transport vesicles along microtubules towards the centrosome (Szebenyi et al., 2007a) . Thus, our experiments demonstrated the existence of a new CRB2 complex at least made of PAR6a, HOOK2 and dynein which is involved in the early steps of primary ciliogenesis.
5) CRB2 participates to the recruitment of PAR6a and HOOK2 to the centriolar region.
HOOK2 and PAR6a are required for either ciliogenesis and/or centrosome organization (Baron Gaillard et al., 2011; ; Kodani et al., 2010) and both CRB2 (this study) and HOOK2 depletion induced a defect in the formation or anchoring of the ciliary vesicle (Baron Gaillard et al., 2011) suggesting that these proteins act together in an early stage of primary ciliogenesis. We thus decided to investigate the role of CRB2 in localizing PAR6a and HOOK2 at the centrosomal region where CRB2 positive vesicles are found close to HOOK2 and MyoVA labeling ( Fig.S3B ). In CRB2 KD cells, PAR6a signal was significantly decreased at the centrosome ( Fig.3B, C) showing that CRB2 controls PAR6a accumulation at the centrosome. In control conditions, HOOK2 was accumulated as spots in the centriolar area and these spots were strongly diminished in the same area of CRB2 KD cells ( Fig.3B,C) while PCM1 granules were more dispersed in CRB2 KD cells than in CT cells. These data demonstrate that CRB2 is necessary for the accumulation of HOOK2 and PCM1 in the centriolar area and of PAR6a at the centrosome. Together these results suggest that CRB2 present in cytoplasmic vesicles (Fig.  1D) , carries PAR6a to the centrosome on microtubules towards the minus end via the dynactin subunit p150 glued through its interaction with PAR6a (Kodani et al., 2010) while HOOK2 enhances the interaction between dynein and dynactin to reinforce this process (Dwivedi et al., 2019a; ; Dwivedi et al., 2019b) .
6) CRB2 depletion is rescued by RAB8A overexpression.
In CRB2 KD as in HOOK2 KD cells, a ciliary vesicle was not formed on the activated MC (this study and (Baron Gaillard et al., 2011) ). We have shown that in the case of HOOK2 depletion we could reverse the membrane transport defect by overexpressing a GFP::RAB8A construct (Baron Gaillard et al., 2011) . To test if CRB2 was acting in the same pathway, we first investigated whether CRB2 interacted with RAB8A by performing coimmunoprecipitation experiments after expression of AU1::CRB2 and a GFP::RAB8A in HEK cells (Fig. 4A ). Indeed, AU1::CRB2 was detected specifically albeit weakly after immunoprecipitations experiments with anti-GFP antibodies indicating that CRB2 and RAB8A belong to a common complex. We next exogenously expressed either GFP or GFP::RAB8A in control cells and CRB2 KD cells and quantified the percentage of GFPpositive cells bearing a cilium ( Fig.4B, C) . Strikingly, in CRB2 KD cells transfected with GFP::RAB8A there was a strong recovery of the ciliogenesis defect (about 5 times more than in the GFP transfected cells) clearly indicating that over-expression of GFP::RAB8A rescued the loss of CRB2. This recovery was similar to the one observed in HOOK2 KD cells (Baron Gaillard et al., 2011) , indicating that CRB2 and HOOK2 act in the same pathway together with RAB8A to build the primary cilium. Therefore, based on these data and previous already published studies, we thus propose a model for the role of this new CRB2 complex in early stages of ciliogenesis ( Fig.  5 ). In this model CRB2 is present in vesicles that are connected to microtubules through its interaction with PAR6a and HOOK2. HOOK2 has been shown to recruit dynein and dynactin to their cargoes to increase the processivity of the complex (Dwivedi et al., 2019b) to transport CRB2 bearing vesicles towards the activated MC. In this context, CRB2 could be considered as the adaptor between the vesicles and the dyneindynactin motor. By this mean, CRB2 also allows to concentrate HOOK2 and PAR6a to the centriolar area. In addition to this mechanism, it has been shown in Drosophila that Crb interacts with MyoV during the transport of Rhodopsin to the rhabdomere of PR (Pocha et al., 2011 ) and while we have not found a loss of MyoVa upon CRB2 depletion we cannot exclude an interaction between the two proteins during the formation of the ciliary vesicle.
More work will be necessary to define the molecular mechanisms behind this step. We hope that by uncovering more of the mechanisms controlled by CRB2 during ciliogenesis will help finding more targets for improving CRB2 syndrome symptoms in patients. The fact that CRB2 and HOOK2 form a complex and that HOOK2 has been recently identified in a screen for RP in human (Patel et al., 2018) reinforces the hypothesis that these two proteins work as a complex in RP degeneration.
MATERIAL AND METHODS
Cell culture and transfection: ARPE19 cells were cultured as in (Baron Gaillard et al., 2011) . To study ciliogenesis, ARPE19 cells were cultured for 7 days in complete medium.
HEK 293F cells were cultured in DMEM with L-Glutamine and 10% fetal bovine serum.
ARPE19 cells were transfected with Dharmafect4 or Dharmaduo transfection reagents for siRNA or cDNA, respectively, using the manufacturer's instructions (Horizon Discovery Dharmacon LTD, Cambridge, United Kingdom). To form aggresomes, mHook2 cDNA was transfected in ARPE19 cells using Fugene HD (Promega France) as described in (Pallesi-Pocachard et al., 2016) . HEK cells were transfected with AU1::CRB2 or GFP::RAB8A or both together using nucleofector kit V and program A-023 of AMAXA Biosystem according to the manufacturer's instructions (Lonza Sales Ltd, Basel, Switzerland).
siRNA:
RNAi-mediated knockdown of CRB2 in ARPE19 cells was carried out using a combination of two on target plus siRNA, siCRB2 05 (J-018054-05: 5' GCA GCU GGC CUA ACA GUAU 3');; siCRB2 07 (J-018054-07: 5' CCU AAA CGA UGG CCA UUG G 3') which knocked down the protein by 79% and 91% (n=3) respectively and together by 94%.
Knockdown of MUPP1 (89%, n=3) and PALS1 (70%, n=3) proteins in ARPE19 cells was carried out by, respectively, siMUPP1 08 (5' GCA CAA GUC CUU AGG CAA UUU 3') and pEGFP control vector was from Invitrogen (ThermoFisher Scientific, Courtaboeuf, France).
Antibodies:
The following primary antibodies were used in this study: rabbit polyclonal antibodies against-CRB2 (ThermoFisher Scientific, PA5-25628, WB: 1/200), ODF2 (Sigma-Aldrich, HPA001874, IF: 1/100), Hook2 (a gift from H. Krämer described previously in (Walenta et al., 2001) , IF/WB: 1/500), MyoVa (Novus Biologicals, NBP1-92156, IF: 1/500), PAR6a (a gift from R. Lammers described previously in (Weyrich et al., 2007) , IF: 1/100), PATJ (homemade, described previously in (Lemmers et al., 2002) , WB: 1/300) and PCM1 (Bethyl Laboratories, A301-149A, WB/IF: 1/1000);; mouse monoclonal antibodies against atubulin (Sigma-Aldrich, clone B-5-1-2, WB: 1/10,000), g-tubulin (Sigma-Aldrich, clone GTU- 
Immunofluorescence staining and analysis: Cultured ARPE19 cells on glass coverslips
were fixed either with 3% PFA for 20 minutes and permeabilized with 1% Triton X100 for 10 minutes, or with methanol for 4 minutes at -20°C, or with ethanol 95% acetic acid 5% for 6 minutes at 4°C (for aggresome labeling). Immunofluorescence staining was processed as described previously in (Pallesi-Pocachard et al., 2016) Western Blot: For Western blot analysis, cells were lyzed in 50 mM Tris-HCL pH 7.4, 150 mM NaCl, 1% Triton X-100 (buffer A) with protease inhibitor cocktail containing 1 μg/ml antipain, 1 μg/ml pepstatin, 15 μg/ml benzamidine, and 1 μg/ml leupeptin. The cell lysates were centrifuged at 100,000g during 30 min and the supernatants were completed with Laemmli buffer and bmercaptoethanol. The proteins were heated and processed by SDS-PAGE, transferred to nitrocellulose, stained with Ponceau red, and immunoblotted with indicated antibodies. The proteins were detected with the Western lightning chemiluminescence reagent plus (Perkin Elmer) and visualized by MyECL imager (ThermoFisher Scientific, Courtaboeuf, France).
Co-immunoprecipitations: HEK cells were transfected with AU1::CRB2 or GFP::RAB8A, or
GFP::RAB8A and AU1::CRB2 cDNA. After 48h, cells were treated as in (Pallesi-Pocachard et al., 2016) . Each pre-cleared lysate was incubated with GFP- Trap interacting proteins were identified by mass spectrometry after in-gel digestion as described in (Mojallal et al., 2014) . in intracellular vesicles (blue) binds to PAR6 (yellow) that in turns interacts with HOOK2 (green) which is an "activating adaptor" of dynein-dynactin complex regulating dynein mobility.
In addition, PAR6 binds to dynactin subunit p150Glued and could stabilized the quaternary complex (PAR6Hook2/dynactin/dynein) in a motility shape. The transmembrane protein CRB2 links the PAR6 PDZ domain via its C-terminal CRB2 domain and could be an adaptor protein between vesicles and dynein-dynactin motors for transport ciliary vesicles (CV) along microtubules to the MC area. Barthelemy-Requin et al. Figure Suppl3 
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